Insider · CIK 0001251779

WEAVER GREGORY L

Reports to the SEC for 9 companies · GAITHERSBURG, MD

sec.gov

Transactions

Companies

Filings

CIK

0001251779

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-01	ALTAltimmune, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+14.5K sh	—	—	54,306
2026-10-01	ALTAltimmune, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−4,379 sh	$2.76	−$12.1K	49,927
2026-10-01	ALTAltimmune, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−14.5K sh	—	—	43,425
2026-07-31	ALTAltimmune, Inc.A Award	Chief Financial Officer	AAward	+1,753 sh	$2.41	+$4,231.742	39,831
2026-04-01	ALTAltimmune, Inc.P Purchase	Chief Financial Officer	PPurchase	+10K sh	$3.15	+$31.5K	38,078
2026-03-06	ALTAltimmune, Inc.P Purchase	Chief Financial Officer	PPurchase	+5,000 sh	$3.54	+$17.7K	28,078
2026-02-26	ALTAltimmune, Inc. · Stock Options (option to buy)A Award	Chief Financial Officer	AAward	+259K sh	—	—	259,000
2026-02-26	ALTAltimmune, Inc. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+111K sh	—	—	111,000
2025-11-11	ALTAltimmune, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+18.8K sh	—	—	28,750
2025-11-11	ALTAltimmune, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−5,672 sh	$4.28	−$24.3K	23,078
2025-11-11	ALTAltimmune, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−18.8K sh	—	—	56,250
2025-10-01	ALTAltimmune, Inc. · Stock Options (option to buy)A Award	Chief Financial Officer	AAward	+167K sh	—	—	166,800
2025-10-01	ALTAltimmune, Inc. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+57.9K sh	—	—	57,900
2025-03-13	ALTAltimmune, Inc.P Purchase	Chief Financial Officer	PPurchase	+10K sh	$5.20	+$52K	10,000
2024-11-11	ALTAltimmune, Inc. · Stock Options (option to buy)A Award	Chief Financial Officer	AAward	+225K sh	—	—	225,000
2024-11-11	ALTAltimmune, Inc. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+75K sh	—	—	75,000
2023-11-15	ATOSATOSSA THERAPEUTICS, INC.S Sale	Director, Former EVP, CFO, & Director	SSale	−50K sh	$0.65	−$32.5K	55
2023-06-20	ATOSATOSSA THERAPEUTICS, INC.P Purchase	Director, Former EVP, CFO, & Director	PPurchase	+50K sh	$0.97	+$48.5K	50,055
2023-06-01	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director, Former EVP, CFO, & Director	AAward	+2.6M sh	—	—	2,600,000
2023-05-04	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director, Former EVP, CFO, & Director	AAward	+125K sh	—	—	125,000
2022-05-13	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director, Former EVP, CFO, & Director	AAward	+50K sh	—	—	50,000
2022-03-02	ATAIAtai Beckley N.V. · Stock OptionA Award	Chief Financial Officer	AAward	+228K sh	—	—	228,000
2021-07-02	ATOSATOSSA THERAPEUTICS, INC.M Exercise/Conversion	Director, Former EVP, CFO, & Director	MExercise/Conversion	+4,581 sh	$5.64	+$25.8K	4,581
2021-07-02	ATOSATOSSA THERAPEUTICS, INC.M Exercise/Conversion	Director, Former EVP, CFO, & Director	MExercise/Conversion	+45K sh	$2.38	+$107K	49,581
2021-07-02	ATOSATOSSA THERAPEUTICS, INC.M Exercise/Conversion	Director, Former EVP, CFO, & Director	MExercise/Conversion	+45K sh	$2.52	+$113K	94,581
2021-07-02	ATOSATOSSA THERAPEUTICS, INC.M Exercise/Conversion	Director, Former EVP, CFO, & Director	MExercise/Conversion	+70K sh	$1.70	+$119K	164,581
2021-07-02	ATOSATOSSA THERAPEUTICS, INC.F Tax Payment	Director, Former EVP, CFO, & Director	FTax Payment	−57.1K sh	$6.40	−$365K	107,497
2021-07-02	ATOSATOSSA THERAPEUTICS, INC.S Sale	Director, Former EVP, CFO, & Director	SSale	−107K sh	$5.58	−$600K	0
2021-07-02	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director, Former EVP, CFO, & Director	MExercise/Conversion	−4,581 sh	—	—	0
2021-07-02	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director, Former EVP, CFO, & Director	MExercise/Conversion	−45K sh	—	—	0
2021-07-02	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director, Former EVP, CFO, & Director	MExercise/Conversion	−45K sh	—	—	0
2021-07-02	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director, Former EVP, CFO, & Director	MExercise/Conversion	−70K sh	—	—	0
2021-06-22	ATAIAtai Beckley N.V.P Purchase	Chief Financial Officer	PPurchase	+4,666 sh	$15.00	+$70K	4,666
2021-06-17	ATAIAtai Beckley N.V. · Stock OptionA Award	Chief Financial Officer	AAward	+67.7K sh	—	—	67,726
2021-05-14	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director, Former EVP, CFO, & Director	AAward	+50K sh	—	—	50,000
2020-05-15	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director, Former EVP, CFO, & Director	AAward	+70K sh	—	—	70,000
2020-03-15	ELOXEloxx Pharmaceuticals, Inc.M Exercise/Conversion	FORMER CHIEF FINANCIAL OFFICER	MExercise/Conversion	+3,750 sh	—	—	11,517
2020-03-15	ELOXEloxx Pharmaceuticals, Inc.F Tax Payment	FORMER CHIEF FINANCIAL OFFICER	FTax Payment	−1,086 sh	$2.85	−$3,095.1	10,431
2020-03-15	ELOXEloxx Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	FORMER CHIEF FINANCIAL OFFICER	MExercise/Conversion	−3,750 sh	—	—	0
2020-01-30	ELOXEloxx Pharmaceuticals, Inc.M Exercise/Conversion	FORMER CHIEF FINANCIAL OFFICER	MExercise/Conversion	+5,000 sh	—	—	9,500
2020-01-30	ELOXEloxx Pharmaceuticals, Inc.F Tax Payment	FORMER CHIEF FINANCIAL OFFICER	FTax Payment	−1,733 sh	$3.91	−$6,776.03	7,767
2020-01-30	ELOXEloxx Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	FORMER CHIEF FINANCIAL OFFICER	MExercise/Conversion	−5,000 sh	—	—	15,000
2020-01-30	ELOXEloxx Pharmaceuticals, Inc.M Exercise/Conversion	FORMER CHIEF FINANCIAL OFFICER	MExercise/Conversion	+5,000 sh	—	—	9,500
2020-01-30	ELOXEloxx Pharmaceuticals, Inc.F Tax Payment	FORMER CHIEF FINANCIAL OFFICER	FTax Payment	−1,733 sh	$3.91	−$6,776.03	7,767
2020-01-30	ELOXEloxx Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	FORMER CHIEF FINANCIAL OFFICER	MExercise/Conversion	+5,000 sh	—	—	15,000
2019-05-17	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director, Former EVP, CFO, & Director	AAward	+45K sh	—	—	45,000
2019-01-31	Zyla Life SciencesStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,083 sh	—	—	0
2019-01-31	Zyla Life SciencesStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−667 sh	—	—	0
2019-01-31	Zyla Life SciencesStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2019-01-31	Zyla Life SciencesStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0

Recent filings

Accepted (ET)
Oct 54
WEAVER GREGORY L0001251779-26-000011
SEC(opens sec.gov)
Aug 34
WEAVER GREGORY L0001251779-26-000009
SEC(opens sec.gov)
Apr 14
WEAVER GREGORY L0001251779-26-000007
SEC(opens sec.gov)
Mar 94
WEAVER GREGORY L0001251779-26-000005
SEC(opens sec.gov)
Feb 274
WEAVER GREGORY L0001251779-26-000002
SEC(opens sec.gov)
Nov 124
WEAVER GREGORY L0001251779-25-000006
SEC(opens sec.gov)
Oct 34
WEAVER GREGORY L0001104659-25-096679
SEC(opens sec.gov)
Mar 144
WEAVER GREGORY L0001104659-25-023724
SEC(opens sec.gov)
Nov 124
WEAVER GREGORY L0001104659-24-116882
SEC(opens sec.gov)
Nov 174
WEAVER GREGORY L0001437749-23-032461
SEC(opens sec.gov)
Jun 204
WEAVER GREGORY L0001437749-23-017896
SEC(opens sec.gov)
Jun 54
WEAVER GREGORY L0001437749-23-016569
SEC(opens sec.gov)
May 54
WEAVER GREGORY L0001437749-23-012872
SEC(opens sec.gov)

Companies

Address

910 CLOPPER ROAD SUITE 201S

GAITHERSBURG, MD, 20878